Discover 1,443 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,443
A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation
for
Microvascular Inflammation
Location: Seattle WA, Vancouver, Edmonton, San Francisco CA,
Sponsor: Biogen
Sex: All
Age: 18 - 70+
Code: NCT07219043
Phase 2, Recruiting
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
for
Locally Advanced Adrenal Cortical Carcinoma,
Location: Seattle WA, Madera CA, Aurora CO, La Jolla CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT06900595
Phase 2, Recruiting
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
for
Metastatic Castration-Resistant Prostate Cancer
Location: Seattle WA, Tacoma WA, San Francisco CA, Los Angeles CA,
Sponsor: Kyntra Bio
Sex: Male
Age: 18+
Code: NCT06842498
Phase 2, Recruiting
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Get alerts for new trials in your area by subscribing now
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Seattle WA, Great Falls MT, Sacramento CA, Billings MT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07061964
Phase 2, Recruiting
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
for
Aortic Arch Dissection, Aortic Arch Aneurysm
Location: Seattle WA, Sacramento CA, Murray UT, Palo Alto CA,
Sponsor: W.L.Gore & Associates
Sex: All
Age: 18+
Code: NCT07166133
Recruiting
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
for
Carcinoma, Hepatocellular, Hepatocellular Cancer,
Location: Seattle WA, Reno NV, Pasadena CA, Los Angeles CA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07227012
Phase 1, Phase 2, Recruiting
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Location: Seattle WA, Stanford CA, Los Angeles CA, La Jolla CA,
Sponsor: XVIVO Perfusion
Sex: All
Age: 18+
Code: NCT06895070
Recruiting
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
for
Non-Squamous Non-Small Cell Lung Cancer, c-MET
Location: Seattle WA, Reno NV, Duarte CA, Santa Monica CA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07005102
Phase 2, Phase 3, Recruiting
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
for
COVID-19 Infection
Location: Seattle WA, Boise ID, Sacramento CA, Granada Hills CA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07013474
Phase 3, Recruiting
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer